bioRxivBioinformaticsPreprint
Evaluating the Potential Blood Coagulant Activity of Caenothus americanus Compounds: Computational Analysis using Docking, Physicochemical, and ADMET Studies
Zahra Sadat MashkaniiD, Zahra Pahlavan YaliiD, Akbar DorgalalehiD, Mahmood ShamsiD
Abstract
Caenothus americanus is a common folk remedy for the treatment of wound bleeding. Certain compounds found in this plant have been shown to reduce clotting time. However, analyzing the effects of various compounds of a folk remedy is a time-consuming and expensive process, therefore, this study employed computational analyses using docking, physicochemical, and pharmacokinetic servers to identify potential clotting activity in C.americanus compounds. The ADMETlab, SwissADME web servers, Discovery Studio, and Autodock were used to study the proper binding to target proteins and predict the physicochemical and ADMET properties (adsorption, distribution, metabolism, excretion, and toxicity) of C. americanus compounds. Coagulation factors including activated factor (F) IIa, FVa, FVIIa, FVIIIa, FIXa, FXa, FXIa, FXIIa, and FXIIIa were chosen as target proteins. Docking studies revealed that malic acid, malonic acid, oxalic acid, and succinic acid were effective on coagulation factors, of which, malic acid had better binding to intrinsic pathway factors including FVIIa, FIIa, and FXIIIa (except FVIIIa), oxalic acid to FVIIIa, and malonic acid to FVa and FXa. Moreover, ADMET studies showed the safety profile of these compounds. In conclusion, carboxylic and alcoholic groups of malic acid, malonic acid, oxalic acid and succinic acid play a role in interaction with blood coagulation factors. Additionally, based on the ADMET characteristics and suitable pharmacokinetic potentials of these compounds, they can be introduced as blood coagulant candidates with fewer side effects in bleeding disorders. However, further studies are necessary to evaluate the precise components of the C. americanus with the suability to bind coagulation factors.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Computational ligands to VKORC1s and CYPs. Could they predict new anticoagulant rodenticides?
A. Bermejo-Nogales, J. M. Navas, J. Coll·bioRxiv·Jan 22, 2021
- Comparative pharmacology of direct oral anticoagulants and vitamin K antagonist.
A. Kumar·bioRxiv·Nov 10, 2022
- Hemodynamics Affects Factor XI/XII Anticoagulation Efficacy in Patient-Specific Left Atrial Models
Manuel Guerrero‐Hurtado, Manuel García‐Villalba, … Óscar Flores·Computer Methods and Programs in BiomedicinePeer-reviewed·Apr 21, 2025
- A novel rationale for targeting FXI: Insights from the hemostatic miRNA targetome for emerging anticoagulant strategies
Jamie P. Nourse, Sven Danckwardt·Pharmacology & TherapeuticsPeer-reviewed·Sep 6, 2020
- A Procoagulant Peptide Analog of the SARS-CoV-2 Nucleocapsid C-terminal Domain
Brian Andrich L. Pollo, Fresthel Monica M. Climacosa, Salvador Eugenio C. Caoili·bioRxiv·Jul 7, 2026
- Targeting von Willebrand factor selectively under inflammatory conditions
Gianluca Interlandi, Victoria S. Carter, … Xiaoyun Fu·bioRxiv·Aug 13, 2025